The RECLAIM study is part of the EU-funded research project “Clinical impact through AI-assisted MS Care” (CLAIMS) and constitutes one of the two clinical studies within the CLAIMS project. The study aims to gather previously collected data from people with Multiple Sclerosis (MS) to create a large database that incorporates both real-world clinical information of people with MS, as well as data from clinical trials in which people with MS participated. This combined dataset will serve as the foundation for developing Artificial Intelligence (AI)-driven models to support the prognosis of an individual’s disease progression and treatment response. Furthermore, the data will be instrumental in advancing our understanding of how MS progresses, and it will allow us to develop new and better tools to monitor this disease progression.


Currently, there are 6 clinical centers participating in the RECLAIM study, with several new clinical centers having shown interest in joining the study. The current 6 centers are : Charité Universitätsmedizin Berlin/Technische Universität Dresden/Ruhr Universität Bochum/CHU Lille/Casa di Cura Igea/General University Hospital in Prague.

If you would like to contribute to the RECLAIM study, the best option would be to make your treating physician aware of this study. If your physician is interested, they can reach out to us via info@claims.ms to see whether their institution or hospital can join the study.

Scroll to Top